Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 820-015-3 | CAS number: 129874-15-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- other company data
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Cuprate(4-), [μ-[4-hydroxy-7-[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-hydroxy-4-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]-3-[(2-hydroxy-4-sulfophenyl)azo]-2-naphthalenesulfonato(8-)]]di-, tetrasodium
- EC Number:
- 277-520-1
- EC Name:
- Cuprate(4-), [μ-[4-hydroxy-7-[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-hydroxy-4-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]-3-[(2-hydroxy-4-sulfophenyl)azo]-2-naphthalenesulfonato(8-)]]di-, tetrasodium
- Cas Number:
- 73513-82-3
- Molecular formula:
- C37H21Cu2N9O17S4.4Na
- IUPAC Name:
- Cuprate(4-), [μ-[4-hydroxy-7-[4-[(2-hydroxyethyl)amino]-6-[[5-hydroxy-6-[(2-hydroxy-4-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]-1,3,5-triazin-2-yl]-3-[(2-hydroxy-4-sulfophenyl)azo]-2-naphthalenesulfonato(8-)]]di-, tetrasodium
- Test material form:
- solid: particulate/powder
- Details on test material:
- Trade name 2076 BENZANIL RUBINE 2BL
Purity: 55-60%
Constituent 1
- Specific details on test material used for the study:
- The substance tested was reported as the trade name Benzanil Rubine 2BL which is Direct Red 83-1. Purity was cited at 55-60% (impurities sodium chloride and water).
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- 3 New Zealand White rabbits (2 females and 1 male), supplied by David Percival Ltd, Moston, Sandbach, Cheshire, UK, were used. At the start of the study the animals weighed 2.73 -2.90 kg and were 12 – 16 weeks old.
Immediately before the start of the test, both eyes of the provisionally selected test rabbits were examined for evidence of ocular irritation or defect with the aid of a light source from a standard ophthalmoscope. Animals showing evidence of ocular lesions were rejected and replaced.
Test system
- Vehicle:
- not specified
- Amount / concentration applied:
- One rabbit was initially treated. A volume of 0.08 ml of the test material, which was found to weight approximately 100 mg was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball.
After consideration of the ocular responses produced in the first treated animal, 2 additional animals were treated. In order to minimize pain on application of the test material, one drop of local anesthetic was instilled into both eyes of these animals 1 – 2 minutes before treatment. - Duration of treatment / exposure:
- The upper and lower eyelids were held together for about 1 second immediately after application, to prevent loss of the test material, and then released. The left eye remained untreated and was used for control purposes. Immediately after administration of the test material, an assessment of the initial pain reaction was made.
- Observation period (in vivo):
- Assessment of ocular damage/irritation was made approximately 1, 24, 48 and 72 hr following treatment, according to Draize (1977) “Dermal and eye toxicity tests.”
Any other ocular effects were also noted. Examination of the eye was facilitated by the use of the light source from a standard ophthalmoscope.
Additional observations were made on Day 7 and 14 to assess the reversibility of the ocular effects. - Number of animals or in vitro replicates:
- 3 rabbits ( 2 females and 1 male)
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 1
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 1
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0
- Max. score:
- 0
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- iris score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 1
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 2
- Reversibility:
- fully reversible within: 14 days
- Remarks on result:
- probability of mild irritation
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- conjunctivae score
- Remarks:
- redness
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1.7
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- probability of mild irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 1
- Reversibility:
- fully reversible within: 7 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 0.7
- Max. score:
- 1
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- probability of weak irritation
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 3 days
- Remarks on result:
- probability of mild irritation
- Irritant / corrosive response data:
- Purple staining of the conjunctive was noted in all treated eyes one hour after treatment and prevented accurate evaluation of conjunctive redness. Purple staining of the iris was noted in 2 treated eyes 1 hour after treatment and prevented accurate evaluation of iridial inflammation in one treated eye at this time. Purple staining of the cornea was noted in 2 treated eyes 1 hour after treatment, in the conjunctivae of all treated eyes at the 24 and 48 hour observation and persisted in the conjunctivae of two treated eyes at the 72 hour observation.
Dulling of the normal luster of the corneal surface was noted in two treated eyes at 1 hr observation. Diffuse corneal opacity was noted in 2 treated eyes at the 24 and 48 hour observations and in 1 treated eye at the 72 hour observation.
Iridial inflammation was noted in 2 treated eyes at the 1, 24 and 48 hr observations.
Slight conjunctival chemosis (swelling) and severe discharge were noted in all treated eyes at the 1-hour observation. Moderate conjunctival irritation was noted in 2 treated eyes at the 24 hour observation and in one treated eye at the 48 hour observation. Minimal conjunctival irritation was noted in one treated eye at the 24 hour observation, 2 treated eyes at the 48 hour observation, all treated eyes at the 72 hour observation and in 1 treated eye at the 7 day observation.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test material, BENZANIL RUBINE 2BL, did not produce positive criteria in any rabbit according to EU labelling regulations. No symbol and risk phrase are therefore required.
- Executive summary:
The study was performed to assess the irritancy potential of the test material following a single application to the rabbit eye, according to OECD 405 guideline. 3 New Zeeland rabbits (2 females and 1 male) were tested by a single administration of the test substance.
A volume of 0.08 ml (100 mg) of the test material was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball.
Assessment of ocular damage/irritation was made approximately 1, 24, 48 and 72 hr following treatment, according to Draize (1977) “Dermal and eye toxicity tests.”
The mean scores of corneal opacity, iritis, conjunctival redness, and conjunctival oedema do not meet the classification criteria. All of the effects reverse within 21 days.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.